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Abstract
Aim – to establish and analyze the spectrum of KIR genes in people with a confirmed diagnosis of Cystic fibrosis (CF), 
homozygote of F508del mutation of the СFTR gene for understanding the genetic predisposition of congenital immunity key part 
functioning during CF. 
Materials and Methods. Examined 48 people with a confirmed diagnosis of CF, homozygotes of the F508del mutation of 
the CFTR gene, and 104 practically healthy people without the F508del mutation of the CFTR gene from the control group. The 
following molecular genetic methods were used: DNA extraction from peripheral blood cells, KIR genotyping by PCR-SSP for the 
presence or absence of the 14 KIR genes (KIR2DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 
3DL3, 3DS1).
Results – molecular genetic studies of KIR-genes repertoire in the group of cystic fibrosis patients showed a decrease in the 
frequency of genes, responsible for activating NK cells receptors. Of the five examined NK cell activation genes, one gene was com-
pletely absent, namely 2DS4, and another (2DS1) was detected in only 3 of 48 patients examined, which was 6.25 %, and this figure 
is significantly lower in comparison with the control group (c2=4.801, p<0.05). Regarding the genes of NK-cell inhibitory receptors, 
all investigated genes were detected in the study group (8 in general). By detection frequency, they mostly correspond to the control 
group, with the exception of the 2DL3 gene, found in patients with CF with a significantly lower frequency (c2=11.97, p<0.005). 
Conclusion – for the first time in the group of patients with CF, a study was performed on the frequency and spectrum of 
KIR-genes, responsible for NK cell receptors. Reducing the frequency of activation NK cell receptor genes in patients with CF can 
lead to a weakening of congenital immunity and the severity of infectious processes during CF.
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1. Introduction
NK (Natural Killers) – cytotoxic cells, whose role is to recognize and eliminate foreign 
antigens. NK cells are directed against pathogenic infections and/or infected and transformed cells 
of their own organism. This is one of the key elements of innate cellular immunity. However, high-
lighting specific cytokines (in particular immune interferon) and thereby affecting the acquired 
humoral immunity, they also play an important immunoregulatory function in the body [1, 2].
Functional activity of NK cells is thoroughly regulated by a complex of receptors that are 
located on the cell surface. These receptors are divided into activating and inhibitory [3]. When ac-
tivating receptors are dominant, the NK cell performs its cytotoxic activity in identifying and elim-
inating target cells, and when inhibitory receptors are included, the cytotoxic activity of the NK 
cells is blocked and no lysis of target cells occurs or significantly slows down [4]. Currently at least 
five major groups of natural killer structural receptors are known, among which the most studied 
are immunoglobulin-like receptors – KIR (killer cell immunoglobulin-like receptor) [3, 5, 6]. KIRs 
are transmembrane glycoproteins with two or three extracellular immunoglobulin-like domains 
(KIR2D and KIR3D, respectively) and a long (L) or short (S) cytoplasmic tail. Receptors with 
L-tail carry out an inhibitory signal, and with S-tail – activating [7, 8].
The KIR genes are polymorphic and highly homologous and they are found in a cluster on 
chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). Currently, 18 KIR genes 
have been identified. The KIRs gene repertoire is characterized by high interindividual polymor-
phism: only 2DL4, 3DL2 and 3DL3 genes and several non-expressed genes are always present, the 
presence of other genes is not unambiguous [8–10]. This, in turn, causes a large heterogeneity of KIR – 
haplotypes. KIR – haplotypes are divided into two groups: A and B, which differ from each other, 
above all, in the total number of genes, coding activating KIR receptors. Group A haplotypes contain 
only one KIR2DS4 activating gene, while haplotypes of group B contain various combinations of 
KIR activation genes, namely KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5, KIR3DS1 [6, 11].
Cystic fibrosis (CF) is the most common monogenic autosomal recessive disease of the euro-
pean race, the carrier frequency of the mutation, responsible for CF – 1:2500 [12]. The cause of the 
disease is the mutation in the gene, responsible for the synthesis of the chlorine transport channel – 
CFTR (cystic fibrosis transmembrane conduction regulator). The so-called major, most common mu-
tation, which in most cases is associated with the early appearance of the first clinical signs of CF and 
with a particularly severe course of the disease, is the mutation of the F508del of the СFTR gene [13].
The greatest threat to life in patients with CF is caused by infections of the upper respiratory 
tract, which are massively multiplied in the good environment, made due to violation of the mucus 
outflow [14]. An accurate prognostic assessment of the treatment outcome is not possible, even in 
cases, where the type of mutation is accurately determined, an identification of the infectious agent is 
carried out and adequate therapy, including antimicrobial, is performed. It is obvious, that the immu-
nological features of the patient with CF, in particular the state of his/her innate immunity, in partic-
ular the cellular component, which is represented by NK cells, plays a role here. All of the above has 
led us to study the genetically determined cytotoxic activity of natural killers in individuals with CF.
The aim of the work was to establish and analyze the spectrum of KIR genes in people with 
a confirmed diagnosis of CF, homozygote of F508del mutation of the СFTR gene for understanding 
the genetic predisposition of congenital immunity key part functioning during CF.
2. Material and Methods
The research material was DNA, isolated from the peripheral blood of 48 people (27 wom-
en and 21 men aged 0 to 30 years) with a confirmed diagnosis of CF, homozygotes of the F508del 
mutation of the СFTR gene, which were screened at the Institute of Hereditary Pathology of the Na-
tional Academy of Medical Sciences of Ukraine and were treated in the inpatient unit of the Western 
Ukrainian Specialized Child Medical Center and 104 practically healthy people (59 women and 45 
men aged 0 to 30 years) without of the F508del mutation of the СFTR gene from the control group. 
KIR genotyping was performed in 2019. The biological material was taken from the DNA 
bank SI “Institute of Hereditary Pathology Ukrainian National Academy of Medical Sciences” for 
the last 10 years. 
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These studies were considered at a meeting of the Committee on Bioethics SI «Institute of 
Hereditary Pathology of the National Academy of Medical Sciences of Ukraine». (Protocol No. 63, 
09.03.2020). The members of the Committee agreed that the materials, provided for the examina-
tion, were scientifically substantiated.
The information letters contain the consent of all patients and parents / guardians of the 
children to use their biological material for research. All measures, concerning patients’ health, 
respect for human rights, human dignity and moral and ethical standards are taken into account 
in accordance with the principles of the Declaration of Helsinki and the European Convention on 
Human Rights.
DNA from peripheral blood lymphocytes was isolated by the solution method [15]. The KIR 
receptor genes were modeled, using polymerase chain reaction with allele specific primers (PCR-SSP, 
polymerase chain reaction with s sequence-specific primers) [16]. The primers were synthesized by 
the company “Sigma”(Germany). The allele characterization was based on the presence or absence 
of a PCR product that was recorded, using 2 % agarose gel electrophoresis, stained with bromine 
acetic acid in UV light at a wavelength of 302 nm.
The statistical analysis of data was carried out, following methods: gene frequencies and 
the theoretically expected distribution of genotypes were calculated, using contingent tables 2×2 
by the Pearson c2 criterion calculation. The verification of statistical hypotheses was carried out at 
the level of significance p≤0.05.
3. Results and Discussion
The presence/absence of 13 KIR genes in a group of 48 people with a confirmed diagnosis 
of CF, homozygote for the F508del mutation of the СFTR gene was analyzed. The range of KIR 
genes in the study group was compared with that in a control, consisting of 104 healthy individ-
uals without the carrier of mutations in the TRBM gene. The results of genotyping are presented 
in Table 1.
In the control group, all 13 detected KIR genes were present. Their frequency ranged from 
10.58 % (for the 2DS4 gene) to 100 % (for structural genes 2DL4, 3DL2 and 3DL3). As can be 
seen from the results presented, the KIR genes of the inhibitory receptors were more frequent 
in the control group than the activation receptor genes. The results we get are in common with 
the results of other researchers [7, 11, 17, 18]. It should be noted, that the primary in evolutionary 
point of view are the inhibitory receptors of NK cells, whose role was to inhibit the cytotoxic ac-
tivity of natural killer cells, in particular, with regard to the cells of their own organism. And as 
the accumulation of foreign antigens in the environment, including disease-causing infections, 
evolutionarily increased the number of activating receptors [19, 20]. This can be explained, in 
particular, by the fact that the Japanese [21], living in a more or less isolated world, predominate 
the haplotype of the group A, which is characterized by the presence of only one activation 
gene KIR2DS4, while the Australian aborigines migrated from different continents, on the con-
trary, predominate the haplotype of the group B with the presence of various combinations of 
many (up to 6) genes of activation KIRs [22]. The combination of activating and inhibitory NK 
receptor cells, obviously, also depends on the risk of infecting an organism with a particular 
infectious factor.
In the continuation of the above, as can be seen from Table 1 and Fig. 1, the spectrum of 
KIR-genes in the studied group of cystic fibrosis patients is calculated by the presence of 12 of the 
13 studied genes. First of all, it should be noted, that of the five investigated genes of NK cell acti-
vation receptors, one gene was completely absent, namely 2DS4, and another (2DS1) was detected 
in only 3 of the 48 patients investigated, which was 6.25 %, and this indicator is significantly lower 
than the control group (c2=4.801, p<0.05). Regarding the genes of NK-cell inhibitory receptors, all 
investigated genes were detected in the study group (8 in general). By frequency, they mostly cor-
respond to the control group, with the exception of the 2DL3 gene. 37.5 % of patients with CF are 
carriers of the 2DL3 inhibitor gene at a control rate of 67.31 %. The statistical calculations showed 
a significantly lower frequency of the 2DL3 gene in the investigated group, compared to the control 
with the values c2=11.97, p<0.005.
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Table 1 
Distribution and frequency of KIR genes in a group of people, diagnosed with CF
KIR gene
Control group, n=104 Patients with cystic fibrosis, n=48
c2 P
n  % n %
2DL1 96 92.31 45 93.75 0.102 >0.05
2DL2 60 57.69 25 52.08 0.419 >0.05
2DL3 70 67.31 18 37.50 11,97 <0.05
2DL4 104 100 47 97.92 2.181 >0.05
2DL5 38 36.54 17 35.42 0.018 >0.05
3DL1 96 92.31 43 89.58 0.312 >0.05
3DL2 104 100 48 100.00 1 –
3DL3 104 100 48 100.00 1 –
2DS1 21 20.19 3 6.25 4.801 <0.05
2DS2 37 35.58 16 33.33 0.073 >0.05
2DS3 34 32.69 15 31.25 0.031 >0.05
2DS4 11 10.58 0 0.00 5.473 <0.05
3DS1 34 32.69 20 41.67 1.155 >0.05
Fig. 1. Spectrum of KIR genes among patients with cystic fibrosis
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Summing up the above results, it is evident, that there is a violation of the spectrum and 
frequency of KIR genes in a group of patients with a diagnosis of cystic fibrosis. Compared with 
the control group, patients with CF are characterized by low frequency of genes, responsible for 
activation NK cell receptors. As CF is accompanied by severe infectious lesions of the upper re-
spiratory tract, the treatment of which is far from always effective, it cannot be ruled out, that the 
genetically induced weakness of the activating receptor site of natural killer cells is affecting this 
process. It should be noted, that we did not meet such studies in the literature, but based on literary 
data, which relate mainly to HIV infection [23–25] and hepatitis C [26–30], it can be concluded, 
that the more gentle progression of the disease correlates with increased activation of the functional 
activity of NK cells.
Study limitations. The limitations of our study are the small sample size due to population 
characteristics.
Prospects for further research. In the future, we plan to expand our research, in par-
ticular, we consider it appropriate to include the study of genes of the Major Histocompatibility 
Complex Class I.
4. Conclusion
For the first time in the group of patients with diagnosed cystic fibrosis, the frequency and 
spectrum of KIR genes, responsible for NK-cell receptors was studied. The results, obtained of 
KIR-genes repertoire in the group of cystic fibrosis patients, showed a decrease in the frequency of 
KIR2DS1 and KIR2DS4 (c2=4.801, p<0.05 and c2=5.473, p<0.05) genes, responsible for activating 
NK cells receptors. Regarding the genes of NK-cell inhibitory receptors, by detection frequency, 
they mostly correspond to the control group, with the exception of the 2DL3 gene, found in patients 
with CF with a significantly lower frequency (c2=11.97, p<0.005). The obtained results indicated a 
change in the frequency and spectrum of KIR genes in cystic fibrosis patients, compared with the 
control group towards the reduced frequency of activation NK cells receptor genes. We assume that 
the established low frequency of genes, responsible for activation NK cell receptors in patients with 
cystic fibrosis, can lead to a weakening of the primary immunity and the severity of the course of 
infectious processes in patients with cystic fibrosis.
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